The Poet Who Built 'ChatGPT for Doctors': Daniel Nadler's OpenEvidence Hits $2.3B Valuation

BOSTON, MA – In a world where tech founders often fit a certain mold, Daniel Nadler stands apart. A Harvard-educated poet with a Ph.D. in history, he has emerged as one of the most impactful visionaries in artificial intelligence, proving that a background in the humanities can be the key to solving complex technical challenges.

His latest venture, OpenEvidence, is being hailed as a revolution in healthcare. It's a specialized AI platform—essentially a "ChatGPT for doctors"—that has rapidly achieved a $2.3 billion valuation since its launch in 2022.

This isn't Nadler's first major success. After selling his first AI startup, Kensho, to S&P Global for nearly $700 million, he turned his attention to a critical problem: modern medicine is drowning in data. With millions of new studies published each year, it's impossible for any single doctor to keep up.

OpenEvidence tackles this head-on. The AI scans and synthesizes millions of medical journals, clinical trials, and research papers in seconds. It provides overwhelmed doctors with instant, evidence-based answers to complex clinical questions, helping them make faster, smarter decisions. The impact has been immediate: the platform is already in use in over 10,000 hospitals and clinical settings worldwide.

The company's financial health is as robust as its technology. It boasts $50 million in yearly revenue and has secured $210 million in funding from a who's who of venture capital, including Google Ventures and Sequoia Capital.

"We are not trying to replace doctors. We are trying to empower them with the collective knowledge of medical science at their fingertips," Nadler stated in a recent interview. "Every second a doctor saves searching for information is another second they can spend with their patient."

The platform is already being credited with helping physicians diagnose rare diseases faster and identify optimal treatment plans based on the very latest research.

Daniel Nadler's journey from poet to AI pioneer is more than just a remarkable business story. It’s powerful proof that the fusion of brains, purpose, and technology can not only build a billion-dollar company but, more importantly, can help save lives.